Mark I. Travin
Dr. Travin's <span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">clinical focus is on cardiac stress testing, radionuclide myocardial (perfusion and metabolic) imaging, and quantitative blood flow.</span><quillbot-extension-portal></quillbot-extension-portal>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Travin's research focus is on cardiac innervation radionuclide imaging with I-123 mIBG and analogous PET tracers, and quantitative blood flow assessment with myocardial perfusion PET.</span><quillbot-extension-portal></quillbot-extension-portal>
<p>Mark I. Travin, MD, FACC, MASNC, is Director of Cardiovascular Nuclear Medicine at Montefiore. He is also a Professor of Radiology and Medicine at our Albert Einstein College of Medicine. His clinical focus is on cardiac stress testing, radionuclide myocardial (perfusion and metabolic) imaging, and quantitative blood flow.</p><p>Dr. Travin earned his Bachelor of Science and Master of Science degrees in 1979 at Yale College, followed by his Doctor of Medicine degree in 1983 from the University of Pennsylvania School of Medicine. After graduating, he went on to complete both an internship and a residency in medicine at Lenox Hill Hospital. In 1986, Dr. Travin began a fellowship in cardiology at the Brown University Integrated Fellowship Program. After that, he went on to complete a clinical and research fellowship in medicine and cardiology, with emphasis in nuclear cardiology at Massachusetts General Hospital and Spaulding Rehabilitation Hospital. </p><p>Dr. Travin?s research focus is on cardiac innervation radionuclide imaging with I-123 mIBG and analogous PET tracers, and quantitative blood flow assessment with myocardial perfusion PET. He has a significant body of published research on cardiac imaging, and has received numerous awards and honors, including the Cardiology Program Director?s Training Award, and the American Society of Nuclear Cardiology 2015 Zaret-Beller Distinguished Journal of Nuclear Cardiology Service Award. </p>
Mark A. Thomas
Tadahisa Sugiura
Dr. Sugiura’s clinical focus is in structural heart disease, coronary artery bypass surgery, the treatment of end-stage heart failure, extracorporeal membrane oxygenation (ECMO), and cardiothoracic organ procurement.<quillbot-extension-portal></quillbot-extension-portal>
Dr. Sugiura’s research focuses on cardiac regenerative therapy, induced pluripotent stem cell (iPS cell) research and stem cell medicine.<quillbot-extension-portal></quillbot-extension-portal>
<p>Tadahisa Sugiura, MD, PhD, is an attending surgeon and Assistant Professor at Montefiore-Einstein. Dr. Sugiura’s clinical focus is in structural heart disease, coronary artery bypass surgery, the treatment of end-stage heart failure, extracorporeal membrane oxygenation (ECMO), and cardiothoracic organ procurement.</p><p>Educated in Japan, Dr. Sugiura attended University of Tsukuba School of Medicine from 1997 to 2003, earning his Doctor of Medicine degree. He began his postdoctoral training with a residency at Tokyo Women’s Medical University from 2003 to 2005, followed by a residency at Seirei Hamamatsu General Hospital in Japan from 2005 to 2007. He then undertook a fellowship at Tokyo Women’s Medical University in 2008, followed by a fellowship at Yokohama City University Medical Center from 2009 to 2011. In 2012, he earned his PhD from Tokyo Women’s Medical University. Dr. Sugiura came to the United States in 2013 and continued his training, completing a research fellowship at Nationwide Children's Hospital, The Ohio State University in 2016. He was an advanced fellow at Texas Heart Institute at Baylor St. Luke’s Medical Center from 2016 to 2018 and a super fellow at Montefiore-Einstein from 2018 to 2019.</p><p>Dr. Sugiura’s research focuses on cardiac regenerative therapy, induced pluripotent stem cell (iPS cell) research and stem cell medicine. He has shared his research through publication in many peer-reviewed journals as well as book chapters, abstracts, posters and presentations. He is also an ad hoc reviewer for several publications including <em>The Annals of Thoracic Surgery and Internal Medicine</em>.</p><p>Dr. Sugiura is board certified and is a member of several professional societies.</p>
Asli S. Sucu
Martina Stehlikova
<p>In-patient internal medicine with a special interest in hematology. Anemia, thrombocytopenia and coagulopathy in hospitalised patients.</p>
Tihomir Stefanec
<p>I am interested in Internal Medicine, Critical Care Medicine and Pulmonary Medicine. My current interest is Critical Care Medicine. </p>
Multidisciplinary Critical Care Medicine (Medical, Surgical, Neurologic, Cardiothoracic).<quillbot-extension-portal></quillbot-extension-portal>
Role of the endothelium and its progenitors in the pathogenesis of disease.<quillbot-extension-portal></quillbot-extension-portal>
<p>Tihomir Stefanec, MD, is Attending Physician, Critical Care Medicine, Assistant Professor, Medicine and Neurology at Montefiore Einstein. His clinical focus is multidisciplinary critical care medicine including medical, surgical, neurologic and cardiothoracic critical care.</p><p>After earning his Doctor of Medicine from the University of Zagreb Medical School in Zagreb, Croatia in 1992, Dr. Stefanec completed an internal medicine internship and residency at Long Island College Hospital in 1997. He then completed a critical care medicine fellowship at Saint Vincent’s Hospital and Medical Center in 1999. Following this, Dr. Stefanec completed a pulmonary medicine fellowship at Memorial Sloan Kettering Cancer Center in 2001.</p><p>Dr. Stefanec’s past research focuses on the role of the endothelium and its progenitors in the pathogenesis of disease. His work has been published in peer-reviewed original publications, reviews, editorials and abstracts, and he has presented nationally.</p><p>Dr. Stefanec is board certified in Internal Medicine, Critical Care Medicine and Pulmonary Medicine by the American Board of Internal Medicine, as well as in Neurocritical Care by the United Council for Neurologic Subspecialties. He has been a Fellow of the American College of Chest Physicians since 2003, and is a member of the American Thoracic Society, the American College of Chest Physicians and the European Respiratory Society.</p>
Seth I. Sokol
Coronary and peripheral arterial disease,
Vitamin D and vascular function,
Heart failure